Published in Arterioscler Thromb Vasc Biol on September 30, 2004
Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Surv Ophthalmol (2008) 1.94
Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus. J Clin Invest (2006) 1.29
PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling. Am J Physiol Lung Cell Mol Physiol (2007) 1.19
Prostaglandins increase trabecular meshwork outflow facility in cultured human anterior segments. Am J Ophthalmol (2007) 1.15
Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn. Pharmacol Rev (2012) 0.97
Drosophila eggshell production: identification of new genes and coordination by Pxt. PLoS One (2011) 0.93
Acute inhibition of superoxide formation and Rac1 activation by nitric oxide and iloprost in human vascular smooth muscle cells in response to the thromboxane A2 analogue, U46619. Prostaglandins Leukot Essent Fatty Acids (2008) 0.92
Drosophila Fascin is a novel downstream target of prostaglandin signaling during actin remodeling. Mol Biol Cell (2012) 0.86
Prostaglandins regulate nuclear localization of Fascin and its function in nucleolar architecture. Mol Biol Cell (2015) 0.81
Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion. Arthritis Res Ther (2010) 0.81
Prostaglandins temporally regulate cytoplasmic actin bundle formation during Drosophila oogenesis. Mol Biol Cell (2013) 0.78
Imaging the effects of prostaglandin analogues on cultured trabecular meshwork cells by coherent anti-stokes Raman scattering. Invest Ophthalmol Vis Sci (2013) 0.77
Hic-5 Mediates TGFβ-Induced Adhesion in Vascular Smooth Muscle Cells by a Nox4-Dependent Mechanism. Arterioscler Thromb Vasc Biol (2015) 0.76
Differential regulation of vascular tone and remodeling via stimulation of type 2 and type 6 adenylyl cyclases in the ductus arteriosus. Circ Res (2010) 0.76
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature (1997) 8.04
Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron (1998) 4.92
The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature (1999) 4.74
Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development (1992) 4.69
Requirement for Wnt3 in vertebrate axis formation. Nat Genet (1999) 4.68
A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell (1999) 4.65
Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell (2001) 4.61
RIGUI, a putative mammalian ortholog of the Drosophila period gene. Cell (1997) 3.24
Assembling a clock for all seasons: are there M and E oscillators in the genes? J Biol Rhythms (2001) 2.62
Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res (1999) 2.51
Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem (2001) 2.40
Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol Biol Cell (1998) 1.87
Two-step affinity purification of U7 small nuclear ribonucleoprotein particles using complementary biotinylated 2'-O-methyl oligoribonucleotides. Proc Natl Acad Sci U S A (1991) 1.76
Biglycan is required for adaptive remodeling after myocardial infarction. Circulation (2008) 1.72
Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin. J Cell Biol (1999) 1.70
Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells. Gastroenterology (2001) 1.66
The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J Neurosci (2000) 1.65
A randomized, blinded, prospective trial to compare the safety and efficacy of three bowel-cleansing solutions for colonoscopy (HSG-01*). Endoscopy (2003) 1.48
Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem (2001) 1.43
Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation (2003) 1.43
Cellular adhesion molecules on vascular smooth muscle cells. Cardiovasc Res (1999) 1.43
[Prevention of reinfarction with 100 mg or 30 mg aspirin daily?]. Z Kardiol (1995) 1.38
The lissencephaly gene product Lis1, a protein involved in neuronal migration, interacts with a nuclear movement protein, NudC. Curr Biol (1998) 1.37
The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.28
Brain induces the expression of an early cell surface marker for blood-brain barrier-specific endothelium. EMBO J (1986) 1.22
Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. J Pediatr (2001) 1.20
Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance. Lancet (1999) 1.16
Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21(WAF1/CIP1) but not p27(KIP1). J Biol Chem (2001) 1.15
Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets (2001) 1.14
Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers. Br J Clin Pharmacol (2001) 1.14
Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. J Thromb Haemost (2011) 1.11
Thromboxane A2 and vascular smooth muscle cell proliferation. Hypertension (1995) 1.09
Differentiation-dependent expression of proteins in brain endothelium during development of the blood-brain barrier. Dev Biol (1986) 1.09
Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin. Eur J Pharmacol (1978) 1.08
Biological clock in total darkness: the Clock/MOP3 circadian system of the blind subterranean mole rat. Proc Natl Acad Sci U S A (2001) 1.07
Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct size. Cardiovasc Res (1984) 1.04
Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes. Eur J Pharmacol (1990) 1.04
Quantitative detection of Clostridium difficile in hospital environmental samples by real-time polymerase chain reaction. J Hosp Infect (2008) 1.04
The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent. Q J Nucl Med Mol Imaging (2007) 1.04
The human PER1 gene is transcriptionally regulated by multiple signaling pathways. FEBS Lett (2000) 1.01
Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis. J Thromb Haemost (2010) 1.01
Antimitogenic actions of organic nitrates are potentiated by sildenafil and mediated via activation of protein kinase A. Mol Pharmacol (2001) 1.00
Epac inhibits migration and proliferation of human prostate carcinoma cells. Br J Cancer (2009) 0.99
The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130. J Biol Chem (2000) 0.99
Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro. Br J Pharmacol (1999) 0.98
Retrovirally mediated expression of decorin by macrovascular endothelial cells. Effects on cellular migration and fibronectin fibrillogenesis in vitro. J Biol Chem (2000) 0.97
Aspirin resistance after coronary artery bypass grafting. J Thorac Cardiovasc Surg (2001) 0.97
Reduction of infarct size by selective stimulation of prostaglandin EP(3)receptors in the reperfused ischemic pig heart. J Mol Cell Cardiol (2000) 0.97
Molecular imaging of matrix metalloproteinases in vivo using small molecule inhibitors for SPECT and PET. Curr Med Chem (2006) 0.96
Stimulatory effects of the multi-kinase inhibitor sorafenib on human bladder cancer cells. Br J Pharmacol (2010) 0.96
Lissencephaly gene (LIS1) expression in the CNS suggests a role in neuronal migration. J Neurosci (1995) 0.96
Prostacyclin rather than endogenous nitric oxide is a tissue protective factor in myocardial ischemia. Am J Physiol (1992) 0.95
Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis. Circ Res (2005) 0.95
PGD2 and its mimetic ZK 110.841 are potent inhibitors of receptor-mediated activation of human neutrophils. Eicosanoids (1991) 0.94
Retroviral overexpression of decorin differentially affects the response of arterial smooth muscle cells to growth factors. Arterioscler Thromb Vasc Biol (2001) 0.94
Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia. J Pharmacol Exp Ther (1981) 0.94
Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat. Kidney Int (1999) 0.93
Prostaglandin D2 (PGD2)--a potent coronary vasoconstrictor agent in the guinea pig isolated heart. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.93
Genetic redundancy strengthens the circadian clock leading to a narrow entrainment range. J R Soc Interface (2013) 0.93
The role of clock genes and rhythmicity in the liver. Mol Cell Endocrinol (2011) 0.93
Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. Thromb Res (2000) 0.93
Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa. Mol Pharmacol (1998) 0.93
Detection of UV-induced RNA:protein crosslinks in snRNPs by oligonucleotides complementary to the snRNA. Nucleic Acids Res (1993) 0.92
Preservation of ischemic myocardium by pinane thromboxane A2. Am J Physiol (1980) 0.92
Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation. Gastroenterology (1999) 0.92
mPer1 and mPer2 mutant mice show regular spatial and contextual learning in standardized tests for hippocampus-dependent learning. J Neural Transm (Vienna) (2005) 0.92
Behavioural food anticipation in clock genes deficient mice: confirming old phenotypes, describing new phenotypes. Genes Brain Behav (2010) 0.92
The contribution of tumour necrosis factor-alpha and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin. Br J Pharmacol (1995) 0.91
High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway. Thromb Haemost (2001) 0.91
Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins. Circ Res (2004) 0.91
The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue. Arzneimittelforschung (1982) 0.90
Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells. Br J Pharmacol (2001) 0.90
Cytotoxic enzyme release and oxygen centered radical formation in human neutrophils are selectively inhibited by E-type prostaglandins but not by PGI2. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.90
PGI2 inhibits ischemia-induced platelet activation and prevents myocardial damage by inhibition of catecholamine release from adrenergic nerve terminals. Evidence for cAMP as common denominator. Thromb Res (1981) 0.90
Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study. Aliment Pharmacol Ther (2013) 0.90
The human asialoglycoprotein receptor is a possible binding site for low-density lipoproteins and chylomicron remnants. Biochem J (1991) 0.89
Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury. J Pharmacol Exp Ther (1993) 0.87
Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro. Biochem Biophys Res Commun (1994) 0.87
Thromboxane-dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: a rationale for the use of low-dose aspirin as an antithrombotic agent. Br J Haematol (1999) 0.87
Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen. Eur J Pharmacol (1997) 0.87
Plasma exchanges in frequently recurrent hemolytic-uremic syndrome in a child. Int J Pediatr Nephrol (1983) 0.87
Loss of expression of the beta subunit of soluble guanylyl cyclase prevents nitric oxide-mediated inhibition of DNA synthesis in smooth muscle cells of old rats. Circ Res (2000) 0.87
PDGF-induced Akt phosphorylation does not activate NF-kappa B in human vascular smooth muscle cells and fibroblasts. FEBS Lett (2000) 0.86
Prostaglandin D2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation. Circ Res (1992) 0.86
Prostacyclin rather than nitric oxide lowers human umbilical artery tone in vitro. Eur J Obstet Gynecol Reprod Biol (1992) 0.86
Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract. Curr Med Chem (2000) 0.86
Tolerance development to antimitogenic actions of prostacyclin but not of prostaglandin E1 in coronary artery smooth muscle cells. Eur J Pharmacol (1998) 0.85
Activation of rat hepatic stellate cells in culture is associated with increased sensitivity to endothelin 1. Hepatology (1998) 0.85
Initial demonstration of rhythmic Per gene expression in the hypothalamus of a non-mammalian vertebrate, the house sparrow. Neuroreport (2001) 0.85
Thrombin-induced mitogenesis in coronary artery smooth muscle cells is potentiated by thromboxane A2 and involves upregulation of thromboxane receptor mRNA. Circulation (1998) 0.84
Increased prostacyclin release from perfused hearts of acutely diabetic rats. Diabetologia (1980) 0.84
Expression, function, and regulation of E-type prostaglandin receptors (EP3) in the nonischemic and ischemic pig heart. Circ Res (1997) 0.84
Prostacyclin-induced coronary vasodilation. Interactions with adenosine, cyclic AMP and energy charge in the rat heart in vitro. Eur J Pharmacol (1980) 0.84